SeaStar Medical Holding Corporation ICU
1.98 USD +0.06 (+3.13%)
Nov 6, 2026, 10:46 AM EST
1.90 Day range 1.98
1.89 52-week range 5.38
- YTD
- -17.50%
- 1 year
- -57.05%
Financial health
Altman Z-Score
-29.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -0.4×
FY 2020 5y median -0.4× FY 2025
P/S 40.3×
FY 2020 5y median 0.0× FY 2025
P/B 4.8×
FY 2020 5y median -2.6× FY 2025
P/FCF -3.7×
FY 2020 5y median -3.7× FY 2025
EV/EBITDA -3.2×
FY 2020 5y median -3.2× FY 2025
EV/Sales 31.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -27.3%
FY 2020 5y median -27.3% FY 2025
Profitability
Gross Margin 95.7%
FY 2020 5y median 0.0% FY 2025
Operating Margin -986.6%
FY 2020 5y median 0.0% FY 2025
Net Margin -984.6%
FY 2020 5y median 0.0% FY 2025
ROE -116.6%
FY 2020 5y median 163.2% FY 2025
ROIC -111.3%
FY 2020 5y median 296.7% FY 2025
ROA -85.8%
FY 2020 5y median -533.1% FY 2025
Growth (YoY)
Revenue 814.1%
FY 2020 FY 2025
Operating Income 31.8%
FY 2020 FY 2025
EPS (diluted) 91.2%
FY 2020 FY 2025
Free Cash Flow 15.0%
FY 2020 FY 2025
Financial Health
Current Ratio 3.6×
FY 2020 5y median 0.2× FY 2025
Quick Ratio 3.6×
FY 2020 5y median 0.2× FY 2025
Debt / Equity 0.1×
FY 2020 5y median -0.4× FY 2025
Net Debt / EBITDA 0.9×
FY 2020 5y median -0.5× FY 2025
Interest Coverage -37.0×
FY 2020 5y median -21.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31